Molecular biology of dysplasia and cancer in inflammatory bowel disease.
Colorectal cancer (CRC) develops from a dysplastic precursor lesion, regardless of whether it arises sporadically, in the setting of high-risk hereditary conditions, or in the context of chronic inflammation like inflammatory bowel disease (IBD). This review focuses on the molecular alterations associated with CRC pathogenesis in IBD. Although none of the molecular alterations to be discussed have yet been integrated into clinical practice, there is potential for molecular diagnostics to enhance the management of patients with long-standing IBD.
Itzkowitz
Steven H
SH
The Dr. Henry D. Janowitz Division of Gastroenterology, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA. steven.itzkowitz@msnyuhealth.org
D015415:Biomarkers; D043171:Chromosomal Instability / Q000235:genetics; D018450:Disease Progression; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications / Q000235:genetics*; D007414:Intestinal Neoplasms / Q000235:genetics*; D008967:Molecular Biology; D011230:Precancerous Conditions / Q000235:genetics
D015415:Biomarkers